Opus Genetics, Inc.
NASDAQ:IRD · NASDAQ Global Market
-$0.01 today
Vol 1.06M · Avg 0.81M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+349.13%
Period High
$5.75
Period Low
$0.91
Latest
$4.07
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Alector, Inc.
NASDAQ:ALEC
$180.42M
TuHURA Biosciences, Inc.
NASDAQ:HURA
$149.65M
Acumen Pharmaceuticals, Inc.
NASDAQ:ABOS
$137.50M
Agenus Inc.
NASDAQ:AGEN
$123.68M
Cognition Therapeutics, Inc.
NASDAQ:CGTX
$102.65M
Seer, Inc.
NASDAQ:SEER
$94.57M
Seres Therapeutics, Inc.
NASDAQ:MCRB
$63.14M
Inovio Pharmaceuticals, Inc.
NASDAQ:INO
$58.15M
Instil Bio, Inc.
NASDAQ:TIL
$51.31M
VistaGen Therapeutics, Inc.
VTGN
$22.45M
What is the latest IRD filing?
The latest filing shown is 424B2 dated Jun 17, 2026.
How many recent filings does IRD have?
Intrinsic Alpha currently shows 20 recent filings for IRD.
Explore More
Continue the stock analysis
Jump to another research area for this company.